New Data Show Incidence of Drowsiness and Sedation is Higher for Some Patients Taking Xyzal(R) (Levocetirizine) Than Patients Prescribed AERIUS(R) [NEOCLARITYN(R)] (Desloratadine) Within one Month of Treatment
Some patients taking Xyzal (levocetirizine) are more likely to experience drowsiness and sedation within one month of treatment than patients prescribed AERIUS [NEOCLARITYN] (desloratadine), according to data published in the October issue of Drug Safety.(1)
The observational ‘real world’ study utilizing the Prescription Event Monitoring (PEM) system conducted by Drug Safety Research Unit (DSRU), an […]